NASDAQ : BMEA
Biomea Fusion, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.6228 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 45.14M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 15.08M | 19.33M | 25.98M | 23.59M | 20.92M | 13.67M |
| Research & Development | 40.78M | 61.98M | 118.08M | 102.55M | 62.71M | 28.00M |
| Operating Expenses | 55.86M | 81.31M | 144.07M | 126.14M | 83.63M | 41.67M |
| Operating Income | -55.86M | -81.31M | -144.07M | -126.14M | -83.63M | -41.67M |
| Interest & Investment Income | 1.85M | 1.86M | 5.64M | 8.88M | 1.95M | 616.00K |
| Other Non Operating Income (Expenses) | 23.17M | 19.86M | ||||
| EBT Excluding Unusual Items | -30.84M | -59.59M | -138.43M | -117.25M | -81.68M | -41.05M |
| Gain (Loss) on Sale of Investments | -1.00K | -144.00K | -516.00K | |||
| Asset Writedown | -2.21M | -2.21M | ||||
| Pretax Income | -32.54M | -61.80M | -138.43M | -117.25M | -81.83M | -41.57M |
| Net Income | -32.54M | -61.80M | -138.43M | -117.25M | -81.83M | -41.57M |
| Net Income to Common | -32.54M | -61.80M | -138.43M | -117.25M | -81.83M | -41.57M |
| Shares Outstanding (Basic) | 69.07M | 52.23M | 36.11M | 34.11M | 29.27M | 23.86M |
| Shares Outstanding (Diluted) | 69.07M | 52.23M | 36.11M | 34.11M | 29.27M | 23.86M |
| EPS (Basic) | -0.47 | -1.18 | -3.83 | -3.44 | -2.80 | -1.74 |
| EPS (Diluted) | -0.47 | -1.18 | -3.83 | -3.44 | -2.80 | -1.74 |
| Free Cash Flow | -47.19M | -70.37M | -120.26M | -99.96M | -63.45M | -38.61M |
| Free Cash Flow Per Share | -0.68 | -1.35 | -3.33 | -2.93 | -2.17 | -1.62 |
| EBITDA | -55.32M | -79.90M | -142.32M | -124.62M | -82.94M | -41.42M |
| D&A For EBITDA | 540.00K | 1.41M | 1.75M | 1.51M | 691.00K | 249.00K |
| EBIT | -55.86M | -81.31M | -144.07M | -126.14M | -83.63M | -41.67M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 34.82M | 55.81M | 58.28M | 176.87M | 111.90M | 145.74M |
| Short-Term Investments | 1.15M | 27.78M | ||||
| Cash & Short-Term Investments | 34.82M | 55.81M | 58.28M | 176.87M | 113.05M | 173.52M |
| Prepaid Expenses | 1.24M | 2.24M | 10.05M | 2.31M | 4.77M | 3.04M |
| Total Current Assets | 36.43M | 58.05M | 68.33M | 179.18M | 117.82M | 176.56M |
| Property, Plant & Equipment | 47.00K | 153.00K | 10.62M | 14.87M | 7.99M | 5.69M |
| Long-Term Investments | 1.88M | |||||
| Other Long-Term Assets | 398.00K | 369.00K | 988.00K | 5.87M | 3.50M | 1.58M |
| Total Assets | 36.87M | 58.57M | 79.94M | 199.93M | 129.31M | 185.71M |
| Accounts Payable | 3.31M | 3.23M | 12.93M | 6.85M | 6.83M | 1.33M |
| Accrued Expenses | 6.11M | 6.24M | 6.46M | 13.35M | 11.02M | 2.26M |
| Current Portion of Leases | 877.00K | 1.46M | 2.08M | 2.47M | 618.00K | 565.00K |
| Other Current Liabilities | 191.00K | 169.00K | 203.00K | 192.00K | 636.00K | 480.00K |
| Total Current Liabilities | 10.48M | 11.10M | 21.67M | 22.86M | 19.10M | 4.64M |
| Long-Term Leases | 128.00K | 6.69M | 7.83M | 1.67M | 2.29M | |
| Other Long-Term Liabilities | 14.25M | 17.79M | ||||
| Total Liabilities | 24.74M | 29.02M | 28.36M | 30.69M | 20.77M | 6.92M |
| Common Stock | 7.00K | 7.00K | 4.00K | 4.00K | 3.00K | 3.00K |
| Additional Paid-In Capital | 481.92M | 478.59M | 438.82M | 418.06M | 240.11M | 228.53M |
| Retained Earnings | -469.79M | -449.05M | -387.25M | -248.82M | -131.57M | -49.74M |
| Comprehensive Income & Other | -1.00K | -10.00K | ||||
| Total Common Equity | 12.14M | 29.55M | 51.57M | 169.24M | 108.54M | 178.78M |
| Shareholders' Equity | 12.14M | 29.55M | 51.57M | 169.24M | 108.54M | 178.78M |
| Total Liabilities & Equity | 36.87M | 58.57M | 79.94M | 199.93M | 129.31M | 185.71M |
| Total Debt | 877.00K | 1.59M | 8.77M | 10.30M | 2.29M | 2.85M |
| Net Cash (Debt) | 33.95M | 54.22M | 49.51M | 166.57M | 110.76M | 170.67M |
| Net Cash Per Share | 0.49 | 1.04 | 1.37 | 4.88 | 3.78 | 7.15 |
| Filing Date Shares Outstanding | 72.48M | 72.30M | 37.57M | 35.89M | 29.61M | 29.12M |
| Total Common Shares Outstanding | 72.48M | 72.30M | 36.31M | 35.87M | 29.56M | 25.30M |
| Working Capital | 25.95M | 46.95M | 46.66M | 156.32M | 98.72M | 171.92M |
| Book Value Per Share | 0.17 | 0.41 | 1.42 | 4.72 | 3.67 | 7.07 |
| Tangible Book Value | 12.14M | 29.55M | 51.57M | 169.24M | 108.54M | 178.78M |
| Tangible Book Value Per Share | 0.17 | 0.41 | 1.42 | 4.72 | 3.67 | 7.07 |
| Machinery | 562.00K | 680.00K | 4.51M | 4.39M | 2.79M | 2.31M |
| Construction In Progress | 4.00K | 3.17M | 81.00K | |||
| Leasehold Improvements | 106.00K | 482.00K | 3.44M | 3.19M | 801.00K | 828.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -32.54M | -61.80M | -138.43M | -117.25M | -81.83M | -41.57M |
| Depreciation & Amortization | 540.00K | 1.41M | 1.75M | 1.51M | 691.00K | 249.00K |
| Asset Writedown & Restructuring Costs | 2.21M | 2.21M | ||||
| Loss (Gain) From Sale of Investments | 1.00K | 144.00K | 516.00K | |||
| Stock-Based Compensation | 6.95M | 9.52M | 19.09M | 14.13M | 10.34M | 6.23M |
| Other Operating Activities | -22.88M | -18.01M | 2.84M | 2.69M | 571.00K | 704.00K |
| Change in Accounts Payable | -4.92M | -9.70M | 6.09M | 2.56M | 2.96M | 640.00K |
| Change in Other Net Operating Assets | 3.97M | 6.00M | -11.24M | -232.00K | 4.71M | -2.21M |
| Operating Cash Flow | -47.19M | -70.37M | -119.89M | -96.59M | -62.42M | -35.44M |
| Capital Expenditures | -362.00K | -3.37M | -1.03M | -3.17M | ||
| Investment in Securities | 1.15M | 28.37M | -30.18M | |||
| Investing Cash Flow | 550.00K | -362.00K | -2.22M | 27.34M | -33.35M | |
| Short-Term Debt Repaid | -36.00K | |||||
| Total Debt Repaid | -36.00K | |||||
| Net Debt Issued (Repaid) | -36.00K | |||||
| Issuance of Common Stock | 25.11M | 67.90M | 1.67M | 163.80M | 1.24M | 153.22M |
| Financing Cash Flow | 25.24M | 67.90M | 1.67M | 163.80M | 1.24M | 153.19M |
| Net Cash Flow | -21.40M | -2.47M | -118.59M | 64.99M | -33.84M | 84.39M |
| Free Cash Flow | -47.19M | -70.37M | -120.26M | -99.96M | -63.45M | -38.61M |
| Free Cash Flow Per Share | -0.68 | -1.35 | -3.33 | -2.93 | -2.17 | -1.62 |
| Levered Free Cash Flow | -27.80M | -42.03M | -78.10M | -62.19M | -29.59M | -22.53M |
| Unlevered Free Cash Flow | -27.80M | -42.03M | -78.10M | -62.19M | -29.59M | -22.53M |
| Change in Working Capital | -955.00K | -3.70M | -5.15M | 2.33M | 7.67M | -1.57M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 46.68M | 87.67M | 140.61M | 518.45M | 247.81M | 216.38M |
| Enterprise Value | 12.73M | 47.91M | 62.22M | 331.45M | 116.78M | 29.96M |
| Last Close Price | 0.64 | 1.24 | 3.88 | 14.52 | 8.43 | 7.45 |
| PB Ratio | 3.82 | 2.97 | 2.73 | 3.06 | 2.28 | 1.21 |
| P/TBV Ratio | 3.82 | 2.97 | 2.73 | 3.06 | 2.28 | 1.21 |
| Debt / Equity Ratio | 0.07 | 0.05 | 0.17 | 0.06 | 0.02 | 0.02 |
| Net Debt / Equity Ratio | -2.80 | -1.83 | -0.96 | -0.98 | -1.02 | -0.95 |
| Net Debt / EBITDA Ratio | 0.61 | 0.68 | 0.35 | 1.34 | 1.33 | 4.12 |
| Net Debt / FCF Ratio | 0.72 | 0.77 | 0.41 | 1.67 | 1.75 | 4.42 |
| Quick Ratio | 3.32 | 5.03 | 2.69 | 7.74 | 5.92 | 37.42 |
| Current Ratio | 3.48 | 5.23 | 3.15 | 7.84 | 6.17 | 38.08 |
| Return on Equity (ROE) | -164.14% | -152.35% | -125.38% | -84.42% | -56.96% | -34.68% |
| Return on Assets (ROA) | -63.45% | -73.38% | -64.35% | -47.89% | -33.19% | -20.98% |
| Return on Capital Employed (ROCE) | -211.70% | -171.30% | -247.30% | -71.20% | -75.90% | -23.00% |
| Earnings Yield | -73.15% | -70.49% | -98.45% | -22.62% | -33.02% | -19.21% |
| FCF Yield | -101.80% | -80.27% | -85.53% | -19.28% | -25.60% | -17.84% |
| Buyback Yield / Dilution | -84.48% | -44.65% | -5.86% | -16.52% | -22.69% | -126.51% |